136 related articles for article (PubMed ID: 24654694)
1. Retrospective analysis of 119 small bowel adenocarcinoma in Chinese patients.
Guo XC; Mao ZY; Su D; Wang LJ; Zhang TT; Bai L
Cancer Invest; 2014 Jun; 32(5):178-83. PubMed ID: 24654694
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy for small bowel adenocarcinoma after curative surgery.
Koo DH; Yun SC; Hong YS; Ryu MH; Lee JL; Chang HM; Kang YK; Kim SC; Han DJ; Lee YJ; Kim TW
Oncology; 2011; 80(3-4):208-13. PubMed ID: 21720183
[TBL] [Abstract][Full Text] [Related]
3. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the FOLFOX/CAPOX regimen for advanced small bowel adenocarcinoma: a three-center study from China.
Zhang L; Wang LY; Deng YM; Wang FH; Feng F; Chen YC; An X; Chen C; Xu RH; Li YH
J BUON; 2011; 16(4):689-96. PubMed ID: 22331723
[TBL] [Abstract][Full Text] [Related]
5. [Surgical Resection and Adjuvant Chemotherapy with FOLFOX6 for Primary Duodenal Adenocarcinoma and Nodal Metastasis Resulted in Complete Remission].
Imamura Y; Sasaki M; Kouyama M; Tazaki T; Sugiyama Y; Nakamura H; Kuroo Y; Nakamitsu A; Daimaru Y; Yabuta Y; Shirai A; Uzuhashi K
Gan To Kagaku Ryoho; 2016 May; 43(5):629-31. PubMed ID: 27210097
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.
Overman MJ; Kopetz S; Lin E; Abbruzzese JL; Wolff RA
Acta Oncol; 2010 May; 49(4):474-9. PubMed ID: 20397775
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma.
Xiang XJ; Liu YW; Zhang L; Qiu F; Yu F; Zhan ZY; Feng M; Yan J; Zhao JG; Xiong JP
Anticancer Drugs; 2012 Jun; 23(5):561-6. PubMed ID: 22481063
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum.
Swartz MJ; Hughes MA; Frassica DA; Herman J; Yeo CJ; Riall TS; Lillemoe KD; Cameron JL; Donehower RC; Laheru DA; Hruban RH; Abrams RA
Arch Surg; 2007 Mar; 142(3):285-8. PubMed ID: 17372054
[TBL] [Abstract][Full Text] [Related]
9. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
Chang MH; Lee IK; Si Y; Lee KS; Woo IS; Byun JH
Cancer Chemother Pharmacol; 2011 Aug; 68(2):317-23. PubMed ID: 20972872
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of small bowel adenocarcinoma treated with Mayo or Xelox regimen: a matched case-control study from a database of 581 patients with colorectal cancer.
Thomsen Lønborg J; Vilmar A; Mård D; Astrup Jensen S; Sørensen JB
Oncol Rep; 2007 Oct; 18(4):1023-9. PubMed ID: 17786369
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of curative and palliative treatment of duodenal adenocarcinoma].
Bendixen M; Dahl S; Fristrup C; Mortensen MB
Ugeskr Laeger; 2010 May; 172(18):1376-9. PubMed ID: 20444409
[TBL] [Abstract][Full Text] [Related]
14. Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.
Huffman BM; Jin Z; Yadav S; Patel S; Nagorney DM; Truty MJ; McWilliams RR; Halfdanarson TR; Mahipal A
Clin Colorectal Cancer; 2019 Sep; 18(3):218-225. PubMed ID: 31178274
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin/5-fluorouracil/leucovorin (FOLFOX4) regimen as an adjuvant chemotherapy in the treatment of advanced jejunal adenocarcinoma: a report of 2 cases.
Chen CW; Wang WM; Su YC; Wu JY; Hsieh JS; Wang JY
Med Princ Pract; 2008; 17(6):496-9. PubMed ID: 18836281
[TBL] [Abstract][Full Text] [Related]
16. [Treatment efficacy of surgical management for liver metastasis from colorectal cancer--a report of 198 cases].
Zhang ZG; Song C; Wang H
Ai Zheng; 2006 May; 25(5):596-8. PubMed ID: 16687081
[TBL] [Abstract][Full Text] [Related]
17. Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy.
Kelsey CR; Nelson JW; Willett CG; Chino JP; Clough RW; Bendell JC; Tyler DS; Hurwitz HI; Morse MA; Clary BM; Pappas TN; Czito BG
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1436-41. PubMed ID: 17689032
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
19. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
20. Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases.
Dexiang Z; Li R; Ye W; Haifu W; Yunshi Z; Qinghai Y; Shenyong Z; Bo X; Li L; Xiangou P; Haohao L; Lechi Y; Tianshu L; Jia F; Xinyu Q; Jianmin X
Ann Surg Oncol; 2012 Sep; 19(9):2860-8. PubMed ID: 22526903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]